Replies to post #194478 on Biotech Values

[DewDiligence]

ENTA's management has misled its shareholders claiming "a double digit" royalties on V-Pak sale.

Disagree. ENTA has always made it clear that the V-Pak royalty rate applies to only the portion of V-Pak sales contractually allocated to ABT-450.